Hundreds of clinical trials are rolled out around the world monthly, and many of them are designed to specifically uncover and manage the medical needs of people with sickle cell disease and trait. We keep an updated list of these global studies here, so you don’t have to go searching for them. There might be active study recruitment and enrollment happening at a site near you. Explore the list below to see the different types of studies, and use the navigation options on the left to get as specific as you would like.
The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.
9 United States sites
9 Brazil sites
6 United Kingdom sites
5 Italy sites
5 Germany sites
5 Belgium sites
4 Spain sites
3 Netherlands sites
3 Colombia sites
3 Greece sites
3 France sites
3 India sites
2 Panama sites
2 Canada sites
2 Lebanon sites
2 Turkey sites
1 South Africa site
1 Kenya site
1 United Arab Emirates site
1 Finland site
1 Ghana site
1 Jordan site
1 Oman site
> 12 Years
Phase 3
The goal of the study is to compare the efficacy and safety of crizanlizumab + standard of care to standard of care alone on renal function in sickle cell disease patients ≥ 16 years with chronic kidney disease due to sickle cell nephropathy.
9 United States sites
5 Brazil sites
4 Spain sites
3 Italy sites
3 Turkey sites
3 United Kingdom sites
2 France sites
2 Greece sites
2 South Africa sites
1 Netherlands site
1 Lebanon site
1 Panama site
> 16 Years
HbSS
Phase 2
The focus of the study is the pathophysiological mechanism of allo-antibody formation after red blood cell transfusion in sickle cell disease patients.
4 Netherlands sites
